IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Chiara Cipollari, Marco Massani et al.|Cancer|2024Cited by 8
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Monica Ortenzi, Matteo Fassan et al.|British journal of surgery|2023Cited by 4
IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal CancerO. De Simoni, Mario Guerrieri, M. Scarpa et al.|Cancers|2026Cited by 3
IMMUNOREACT 13: immune features of healthy rectal mucosa as predictors of invasion risk in stage II rectal cancerGiorgio Rivella, Michele Antoniutti, Melania Scarpa et al.|British journal of surgery|2025Cited by 0
Gut microbiota-associated predictors as biomarkers of neoadjuvant treatment response in rectal cancer-a systematic reviewAstghik Stepanyan, Licia Laurino, Andromachi Kotsafti et al.|British Journal of Cancer|2026Cited by 0